Public and Private Funding Fuels the Demand for Metabolomics Global Market to Reach $6.3 billion by 2030
The latest version of the report from Industry Experts, Inc., on "Metabolomics Market", is published. As per this report, the global market for Metabolomics is estimated at US$3.1 billion in 2024 and is projected to reach US$6.3 billion by 2030, growing at a CAGR of 12.6%.
Metabolomics market is witnessing rapid growth, fueled by significant funding from government and private sectors in research and development, alongside ongoing technological progress in analytical methods such as mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. The rising incidence of chronic illnesses, such as cancer, diabetes, cardiovascular, and neurological disorders, is driving demand for metabolomics. Metabolomics plays a crucial role in biomarker identification, enabling early disease detection and facilitating personalized treatment approaches.
The efficacy biomarkers segment is anticipated to witness the fastest growth rate with a CAGR of 14.9% from 2024 to 2030, owing to its crucial role in assessing drug efficacy and forecasting patient responses. Efficacy biomarkers facilitate personalized medicine, improve therapeutic results, and are essential for the success of clinical trials, driving their integration into precision medicine and drug discovery efforts.
The market size for metabolomics analyzed in this report on a global basis covering all major regions across North America (The United States, Canada), Europe (Germany, France, the United Kingdom, Italy, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific) and Rest of World.
This study analyzes the global market for metabolomics based on Analytical Technique – Separation Techniques (High Performance Liquid Chromatography [HPLC], Gas Chromatography, Ultra Performance Liquid Chromatography [UPLC] and Capillary Electrophoresis), Detection Techniques (Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based); Application – Biomarker Discovery, Drug Discovery, Personalized Medicine, Toxicology Testing, Nutrigenomics and Other Applications [Including Functional Genomics, and Clinical Diagnostics]; Indication – Oncology, Cardiology, Neurology, Inborn Errors of Metabolism and Other Indications [Including Inflammatory Diseases, Infectious Diseases, and Rare Diseases, and others].
About Industry Experts, Inc.
Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers, and startups, among others, to obtain valuable, crisp, and unbiased current and future market data. For more information, contact us at +1-320-497-3787 or visit https://industry-experts.com/
Comments
Post a Comment